Pharmacokinetics of L-Carnitine
For GLP-1 drugs, 47% of respondents indicated costs over the next three years are very concerning/significantly concerning. Respondents in Mercers November National Survey of Employer-Sponsored Health Plans also said they expect to see health benefits rise by 6.7% this year, reaching more than $18,500 per employee on averageup from $17,964 in 2025.
GLP-1 medications mimic this hormone to reduce cravings, support portion control, and promote steady, sustainable weight loss
Queen helps patients approach this therapy thoughtfully, combining evidence-based medicine with personalized care
(Native, unmodified recombinant human IGF-1, sold as mecasermin/Increlex, is FDA-approved only for a narrow pediatric growth-failure indication and is chemically distinct from the LR3 analog.) In the US it is manufactured and sold almost exclusively as an unregulated "research chemical" labeled "not for human consumption," a labeling practice peptide vendors use to avoid marketing it as an unapproved drug
Metabolic Health Improvements in blood sugar, insulin sensitivity, and inflammatory markers are particularly valuable for women melanotan metabolic benefits